David M. Charytan - Publications, H-index & Citations

David M. Charytan

NYU Grossman School of Medicine

61H指数

315论文数

2.3W被引数

收录论文 154

发表时间

Platelet Reactivity Expression Score and Major Adverse Cardiovascular and Limb Events in CKD 血小板反应性表达评分与慢性肾脏病患者主要心血管和肢体不良事件

American Journal of Kidney Diseases

IF8.2

2026-07-27

PREAI

Carine E. Hamo; Matthew A. Muller; Tessa J. Barrett; Lila Murphy; Kelly V. Ruggles; Josef Coresh; Morgan E. Grams; David M. Charytan; Jeffrey S. Berger

Cardiac gated diffusion-weighted MR imaging assessment of kidney function in kidney cancer patients 心脏门控扩散加权MR成像对肾癌患者肾功能评估

Kidney International Reports

IF5.7

2026-03-11

OAAI

Nima Gilani; Nalini Jeet; William C. Huang; Vasishta S. Tatapudi; Fang-Ming Deng; Kent Friedman; Karolina Soltys; Mary Bruno; Malika Kumbella; Michal L. Melamed; David M. Charytan; Xiaochun Li; Judith D. Goldberg; Artem Mikheev; Shavy Nagpal; Hersh Chandarana; Eric E. Sigmund

Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis 用于减少血液透析中疼痛和吗啡类药物使用的HOPE联盟试验的质量控制方法

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2025-12-01

PREAI

Nigwekar, Sagar U.; Dember, Laura M.; Kalim, Sahir; Charytan, David M.; Kuzla, Natalie; Kimmel, Paul L.; Cukor, Daniel; Esserman, Denise; Mishra, Puneet; Silva, Kimberly; Steffen, Alana D.; Vassilieva, Svetlana; Williams, Joey; Wetmore, James B.

Chronic Pain Locations, Characteristics, and Associations With Other Symptoms in Adults Receiving Maintenance Hemodialysis: Findings From the HOPE Consortium Trial 维持性血液透析成人慢性疼痛的部位、特征及其与其他症状的关联：HOPE Consortium Trial研究的结果

American Journal of Kidney Diseases

IF8.2

2025-11-12

OAAI

Michael J. Fischer; Jesse Y. Hsu; Joanna Walsh; Kerri L. Cavanaugh; David M. Charytan; Susan T. Crowley; Daniel Cukor; Laura M. Dember; Ardith Z. Doorenbos; Denise Esserman; Manisha Jhamb; Kirsten L. Johansen; Francis J. Keefe; Paul L. Kimmel; Mark B. Lockwood; Rajnish Mehrotra; Benjamin J. Morasco; Sagar Nigwekar; Patrick Pun; Rudy Qamhiyeh

Fish Oil for Patients Receiving Hemodialysis - Red Herring or Great Catch?鱼油用于接受血液透析的患者——是“红鲱鱼”还是“大丰收”？

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2025-11-01

PREAI

Mc Causland, Finnian R.; Charytan, David M.

COVID-19 Pandemic-induced Healthcare Disruption and Chronic Kidney Disease Progression COVID-19疫情导致的医疗中断与慢性肾脏病进展

Journal of General Internal Medicine

IF4.2

2025-09-04

PREAI

Richard Liu; Rahul Abraham; Sarah E. Conderino; Rania Kanchi; Saul B. Blecker; John A. Dodson; Lorna E. Thorpe; David M. Charytan; Mara A. McAdams-DeMarco; Wenbo Wu

Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial (vol 20, pg 1247, 2025)维持性血液透析患者跌倒风险：HOPE Consortium Trial（第20卷，第1247页，2025年）的二次分析

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2025-09-01

PREAI

Charytan, David M.; Moss, Alvin H.; Shalak, Manar; Wu, Wenbo; Dember, Laura M.; Hsu, Jesse Y.; Kuzla, Natalie; Esserman, Denise; Kalim, Sahir; Kimmel, Paul L.; Lockwood, Mark B.; Miyawaki, Nobuyuki; Pellegrino, Beth; Pun, Patrick H.; Qamhiyeh, Rudy; Scherer, Jennifer; Schrauben, Sarah; Weiner, Daniel E.; Mehrotra, Rajnish

Requiem for mineralocorticoid blockade in maintenance dialysis 糖皮质激素阻滞在维持性透析中的安魂曲

lancet

IF0

2025-08-18

PREAI

Qandeel H Soomro; David M Charytan

Corrigendum to “Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.” Kidney International 2025;107:169–179 勘误：“3.0 mmol/l透析液钾浓度与锆基环硅酸盐相比，在无透析日对高钾血症血液透析患者心律失常发生率的影响，以及2.0 mmol/l透析液钾浓度单独使用对心律失常发生率的影响。”《肾脏国际杂志》2025;107:169–179

Kidney International

IF12.6

2025-05-20

OAAI

David M. Charytan; Wolfgang C. Winkelmayer; Christopher B. Granger; John P. Middleton; Charles A. Herzog; Glenn M. Chertow; James M. Eudicone; Jeremy D. Whitson; James A. Tumlin;

Implementation of Ambulatory Kidney Supportive Care in a Safety Net Hospital

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

IF3.5

2025-04-01

PREAI

Scherer, Jennifer S.; Gore, Radhika J.; Georgia, Annette; Cohen, Susan E.; Caplin, Nina; Zhadanova, Olga; Chodosh, Joshua; Charytan, David; Brody, Abraham A.

Neighborhood Built Environment and Home Dialysis Utilization: Varying Patterns by Urbanicity-Dependent Patterns and Implications for Policy 社区建成环境与居家透析利用率：基于城市密集度差异的模式及政策启示

American Journal of Kidney Diseases

IF8.2

2025-03-11

PREAI

Byoungjun Kim; Yiting Li; Myeonggyun Lee; Sunjae Bae; Matthew F. Blum; Dustin Le; Josef Coresh; David M. Charytan; David S. Goldfarb; Dorry L. Segev; Lorna E. Thorpe; Morgan E. Grams; Mara A. McAdams-DeMarco

Pain Coping Skills Training for Patients Receiving Hemodialysis: The HOPE Consortium Randomized Clinical Trial 血液透析患者疼痛应对技能培训：HOPE联盟随机临床试验

JAMA INTERNAL MEDICINE

IF23.3

2025-02-01

PREAI

Dember, Laura M.; Hsu, Jesse Y.; Mehrotra, Rajnish; Cavanaugh, Kerri L.; Kalim, Sahir; Charytan, David M.; Fischer, Michael J.; Jhamb, Manisha; Johansen, Kirsten L.; Becker, William C.; Pellegrino, Bethany; Eneanya, Nwamaka D.; Schrauben, Sarah J.; Pun, Patrick H.; Unruh, Mark L.; Morasco, Benjamin J.; Mehta, Mansi; Miyawaki, Nobuyuki; Penfield, Jeffrey; Bernardo, Leah; Brintz, Carrie E.; Cheatle, Martin D.; Doorenbos, Ardith Z.; Heapy, Alicia A.; Keefe, Francis J.; Krebs, Erin E.; Kuzla, Natalie; Nigwekar, Sagar U.; Schmidt, Rebecca J.; Steel, Jennifer L.; Wetmore, James B.; White, David M.; Kimmel, Paul L.; Cukor, Daniel

Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial 卡格列净在老年人中的心血管，肾脏和安全性结果: 来自CANVAS计划和cre登斯试验的联合分析

DIABETES OBESITY & METABOLISM

IF5.7

2025-01-09

PREAI

Siriwardana, Amanda; Buizen, Luke; Jun, Min; Kotwal, Sradha; Arnott, Clare; Jardine, Meg J.; Levin, Adeera; Heerspink, Hiddo J. L.; Charytan, David M.; Pollock, Carol; Perkovic, Vlado; Neuen, Brendon L.

Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia 3.0 mmol/l透析液钾浓度下，钠锆环硅酸盐对无透析日与2.0 mmol/l透析液钾浓度单独使用对心房颤动发生率的比较，在伴有高钾血症的血液透析患者中的应用。

KIDNEY INTERNATIONAL

IF12.6

2025-01-01

OAAI

Charytan, David M.; Winkelmayer, Wolfgang C.; Granger, Christopher B.; Middleton, John P.; Herzog, Charles A.; Chertow, Glenn M.; Eudicone, James M.; Whitson, Jeremy D.; Tumlin, James A.

Alzheimer Disease-Related - Related Biomarkers in Patients on Maintenance Hemodialysis

KIDNEY MEDICINE

IF3.4

2024-11-01

OAAI

Masurkar, Arjun, V; Bansal, Nisha; Prince, David K.; Winkelmayer, Wolfgang C.; Ortiz, Daniela F.; Ramos, Gianna; Soomro, Qandeel; Vedvyas, Alok; Osorio, Ricardo S.; Bernard, Mark A.; Debure, Ludovic; Ahmed, Wajiha; Boutajangout, Allal; Wisniewski, Thomas; Charytan, David M.

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial semaglutide与2型糖尿病慢性肾脏疾病严重程度的心血管结局: FLOW试验

EUROPEAN HEART JOURNAL

IF35.6

2024-08-30

OAAI

Mahaffey, Kenneth W.; Tuttle, Katherine R.; Arici, Mustafa; Baeres, Florian M. M.; Bakris, George; Charytan, David M.; Cherney, David Z., I; Chernin, Gil; Correa-Rotter, Ricardo; Gumprecht, Janusz; Idorn, Thomas; Pugliese, Giuseppe; Rasmussen, Ida Kirstine Bull; Rasmussen, Soren; Rossing, Peter; Sokareva, Ekaterina; Mann, Johannes F. E.; Perkovic, Vlado; Pratley, Richard

Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study

KIDNEY360

IF3

2024-08-06

OAAI

Ravi, Katherine Scovner; Tumlin, James A.; Roy-Chaudhury, Prabir; Koplan, Bruce A.; Costea, Alexandru I.; Kher, Vijay; Williamson, Don; Mcclure, Candace K.; Charytan, David M.; Mc Causland, Finnian R.

Gender Differences in Citation Rate

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2024-08-06

PREAI

Soomro, Qandeel H.; Li, Shuojohn; McCarthy, Angela; Varela, Dalila; Ways, Javaughn; Charytan, Amalya M.; Keane, Colin; Ramos, Giana; Nicholson, Joey; Charytan, David M.

IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial (May, 10.1038/s41591-024-03043-1, 2024)

NATURE MEDICINE

IF50

2024-07-03

OAAI

Chertow, Glenn M.; Chang, Anna Marie; Felker, G. Michael; Heise, Mark; Velkoska, Elena; Fellstrom, Bengt; Charytan, David M.; Clementi, Regina; Gibson, C. Michael; Goodman, Shaun G.; Jardine, Meg; Levin, Adeera; Lokhnygina, Yuliya; Mears, Jenny; Mehran, Roxana; Stenvinkel, Peter; Wang, Angela Yee-Moon; Wheeler, David C.; Zoccali, Carmine; Ridker, Paul M.; Mahaffey, Kenneth W.; Tricoci, Pierluigi; Wolf, Myles

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial semaglutide联合或不联合使用SGLT2抑制剂对FLOW试验中2型糖尿病和慢性肾脏疾病参与者的影响

NATURE MEDICINE

IF50

2024-06-24

OAAI

Mann, Johannes F. E.; Rossing, Peter; Bakris, George; Belmar, Nicolas; Bosch-Traberg, Heidrun; Busch, Robert; Charytan, David M.; Hadjadj, Samy; Gillard, Pieter; Gorriz, Jose Luis; Idorn, Thomas; Ji, Linong; Mahaffey, Kenneth W.; Perkovic, Vlado; Rasmussen, Soren; Schmieder, Roland E.; Pratley, Richard E.; Tuttle, Katherine R.

研究方向